AI in healthcare: trust hinges on governance, not hype

Clinician trust in AI tools fundamentally hinges on their ability to enhance clinical workflows by saving time and delivering accurate, clinically relevant information. As early as May 2026, clinicians valued AI that reduced administrative burdens, enabling them to focus more on patient care and foster deeper patient connections, a sentiment echoed by Lee Health’s CEO who emphasized AI should augment rather than replace clinical judgment. This practical value is amplified when AI tools demonstrate clear safety guardrails and alignment improvements, such as those announced by OpenAI, which have helped alleviate earlier concerns about AI reliability in healthcare.

Preserving human judgment and embedding continuous human oversight are critical to building and sustaining clinician trust in AI. Healthcare professionals expect AI systems to recognize their limitations, including the ability to say 'I don’t know,' reflecting a core clinical principle. This is reinforced by strict safety guardrails, traceability, and error handling protocols that prevent AI from providing misleading or outdated advice. Clinicians also insist on maintaining final accountability, underscoring that legal and ethical responsibility remains with the human provider, not the AI system.

Trust grows strongest when AI tools are integrated within mature digital environments supported by clear institutional policies, IT infrastructure, and clinician involvement in governance and evaluation. The experience of Quebec doctors highlights that clinicians adopt AI more readily when they retain control over outputs and use AI as a collaborative assistant, verifying AI-generated insights as they would a colleague’s opinion. Health systems like Lee Health and AI-native organizations further demonstrate that engaging clinicians as super users and advisors fosters honest dialogue, continuous improvement, and alignment with patient care priorities.

Addressing privacy and liability concerns remains a non-negotiable prerequisite for clinician acceptance of AI in healthcare. By mid-2026, privacy and medical liability were identified as 'red lines' that could halt AI adoption despite technological advances. Transparent communication and education efforts, such as Lee Health’s community engagement events, are essential to build trust and dispel fears. Ultimately, clinicians measure AI success not by technology adoption alone but by demonstrable improvements in patient outcomes and the ability to offload lower-value tasks, allowing more time for critical human judgment and patient interaction.

By mid-2026, healthcare leaders like those at HCA and Akido underscored that successful AI adoption hinges on strong enterprise-level leadership that frames AI as a business transformation rather than a series of isolated pilots. Jim McGee of Akido emphasized viewing AI integration through a strategic lens focused on expanding access to high-quality care, while HCA’s investment in extensive training and physician overhaul illustrates the scale of organizational change required. This top-down commitment ensures AI becomes embedded as a core capability, aligning investments with clear ROI and patient-centered outcomes rather than transient technology experiments.

Effective AI adoption demands seamless collaboration between clinical, technical, and leadership teams to build trust and foster shared ownership of AI tools. Akido’s approach of involving physician super users alongside engineering teams working 'at the elbow' with clinicians exemplifies how honest dialogue and co-designed workflows can overcome resistance and refine integration. Similarly, Lee Health’s emphasis on augmenting rather than replacing clinicians, supported by governance structures involving clinicians in evaluation and workflow design, highlights the necessity of clinical leadership in guiding responsible AI use.

Governance and accountability are foundational to responsible AI deployment, requiring enterprise leadership to establish oversight mechanisms that balance innovation with risk management. Akido’s Clinical AI Advisory Council, composed of medical directors and external experts, serves to challenge assumptions and keep AI development aligned with patient care priorities. Meanwhile, Muralidhar Vemulapalli stresses that AI decisioning must include human oversight to prevent harmful automated approvals, reflecting a shared incentive among providers and regulators to ensure AI tools deliver safe, accurate advice and maintain trust.

The shift toward AI as a practical, integrated support tool rather than a standalone pilot is evident in mature digital environments like Quebec hospitals, where clinicians benefit from structured records, IT support, and clear policies that ease AI adoption. This operational maturity enables AI to reduce administrative burdens while reshaping clinical habits under careful governance, ensuring physicians retain control over critical decisions. Enterprise leadership at organizations like Lee Health further reinforces this by prioritizing transparency and community engagement, recognizing that successful AI adoption is as much about people and processes as technology, with ongoing evaluation of its impact on care quality and clinician workload.

By mid-2026, healthcare AI governance frameworks had evolved to encompass rigorous regulatory compliance and risk management protocols essential for clinical-grade AI deployment. These frameworks integrate FDA regulatory pathways, including device classification and pre-submission engagement, alongside adherence to ISO 14971 risk management standards and HIPAA cybersecurity requirements to safeguard patient data. Quality management systems compliant with FDA’s QMSR 21 CFR Part 820 and structured change management processes, such as Predetermined Change Control Plans, ensure safe adaptation of evolving AI models, while continuous real-world performance monitoring supports ongoing oversight of AI tools in clinical practice.

Hackensack Meridian Health’s pioneering achievement of the Joint Commission’s Responsible Use of AI in Healthcare Certification in 2026 set a national benchmark, underscoring the critical role of comprehensive governance structures in responsible AI adoption. Their framework includes multidisciplinary committees, rigorous evaluation, ongoing monitoring, and role-specific staff training, reflecting a shift where governance—not technology—has become the primary bottleneck in AI deployment. This certification, developed with the Coalition for Health AI, emphasizes patient safety, transparency, risk and bias reduction, and operational accountability, signaling a hardening regulatory landscape that pressures health systems to document and sustain governance models, especially as physical AI systems introduce unique safety challenges.

Effective AI governance demands more than policy—it requires operational rigor, multidisciplinary involvement, and clear accountability to bridge the gap between rapid AI adoption and safe clinical integration. Hackensack Meridian’s approach, which includes legal, clinical, academic, and patient perspectives supported by standardized evaluation rubrics, highlights the necessity of scrutinizing vendor data access and maintaining patient data ownership. As Dr. Klein cautions, 'speed should not override governance,' emphasizing that local validation against hospital-specific data, continuous monitoring for model drift, and explicit assignment of accountability before deployment are indispensable to mitigate risks and ensure AI tools deliver equitable, reliable outcomes.

Accreditation programs like URAC’s Health Care Artificial Intelligence Accreditation and organizational efforts such as MMRO’s governance program exemplify the emerging industry standards that operationalize AI governance across the full technology lifecycle. These frameworks prioritize transparency, risk management, and ethical deployment, requiring evidence of governance embedded in workflows rather than mere policy declarations. As Shawn Griffin, MD, URAC’s CEO, states, organizations need governance that enables safe, ethical, and transparent AI use. MMRO’s commitment to exclude AI from autonomous clinical decision-making further illustrates a cautious approach that balances innovation with patient safety, reinforcing that trustworthiness arises from robust governance foundations and continuous oversight rather than model accuracy alone.

By mid-2026, formal certifications such as The Joint Commission’s Responsible Use of AI in Healthcare and URAC’s AI Accreditation emerged as pivotal trust enablers, setting rigorous benchmarks that extend well beyond baseline regulatory approvals. Hackensack Meridian Health’s distinction as the first U.S. health system to earn The Joint Commission’s certification exemplifies how comprehensive, network-wide AI governance frameworks—including multidisciplinary oversight, rigorous evaluation, ongoing monitoring, and role-specific training—are critical to operationalizing responsible AI at scale. This certification not only validates patient safety and operational accountability but also signals a hardening regulatory landscape that increasingly demands documented governance models to mitigate risks and maintain public trust.

URAC’s inaugural Health Care Artificial Intelligence Accreditation further advances the industry’s governance standards by scrutinizing AI across its entire lifecycle with a focus on risk management, transparency, and operational oversight. Pioneering organizations like Guidehealth, RediMinds, and SandsRx have demonstrated leadership by achieving this accreditation, which was developed with input from major stakeholders including Verily, Pfizer, and Northwell Health. URAC President Shawn Griffin, MD, underscores that successful AI deployment demands more than innovative technology—it requires robust governance frameworks that ensure safety, ethics, and transparency, effectively addressing challenges such as 'shadow AI' and data privacy.

The certification processes at Hackensack Meridian Health and MMRO reveal that achieving accreditation is not a mere milestone but a proof-of-concept for repeatable, scalable governance models that shift the focus from initial AI adoption to sustained oversight. Hackensack Meridian’s approach, involving a multidisciplinary team and standardized evaluation rubrics, emphasizes disciplined governance over rapid deployment, with clear policies on vendor data use to protect patient privacy. Similarly, MMRO’s accreditation highlights the importance of clinical integrity and human oversight, ensuring AI tools augment rather than replace clinical judgment, reinforcing organizational commitments to quality and security as AI integration deepens.

As AI technologies evolve to include physical AI systems like autonomous robots, certification frameworks such as The Joint Commission’s are beginning to address the unique governance and safety challenges these tools present. Unlike software-based AI, physical AI carries distinct risk profiles that demand additional validation and controls, underscoring the need for tailored governance frameworks. This emerging focus reflects a broader recognition that procurement and IT teams must evaluate AI vendors not only on technological capabilities but also on how AI tools are governed and monitored post-deployment, aligning with increasing scrutiny from payers, regulators, and accreditors.

The rapid adoption of AI in healthcare has outpaced the establishment of robust governance frameworks, leading to significant challenges in ensuring safe, ethical, and effective AI use. Hospitals and health systems often deploy AI tools without local validation against their unique patient populations or workflows, risking inaccuracies and bias, as national benchmarks fail to capture local nuances. Continuous monitoring is essential to detect model drift and maintain accuracy over time, yet many organizations lack dedicated testing environments or standing processes for post-deployment oversight, highlighting a critical gap between AI implementation and governance maturity.

Shadow AI—unauthorized use of AI tools by healthcare staff—poses a hidden but serious threat to data privacy and cybersecurity, exacerbated by phenomena like the mosaic effect where anonymized data can inadvertently reveal patient identities. This practice circumvents IT oversight and violates HIPAA regulations, as seen in widespread use of chatbots, Microsoft Copilot, and ambient scribes without formal approval. Experts like Jason Jones and Rex Crosby stress that bridging the gap between policy and practice requires auditing current AI use, forming cross-functional governance groups, and enforcing strict vendor vetting to ensure HIPAA compliance and accountability.

Human oversight remains indispensable in healthcare AI, especially in clinical contexts where accountability and patient safety are paramount. Thought leaders such as Muralidhar Vemulapalli and Kevin Dunnahoo emphasize that AI can assist but cannot replace qualified human decision-makers who must validate outputs, own final decisions, and maintain error handling protocols. This oversight shifts human roles from task execution to supervising AI systems, requiring named individuals with override authority and tiered review processes focused on high-risk decisions to prevent harm and ensure compliance.

Effective AI governance in healthcare demands continuous validation, comprehensive audit readiness, and clear accountability frameworks before deployment. Accreditation efforts reveal that trustworthiness stems not from model accuracy alone but from the governance foundation built around AI tools, including unique agent IDs, least privilege access, and robust audit logging to reconstruct events. Boards increasingly demand annual AI governance reviews to understand and control AI deployments, reflecting growing awareness of legal risks such as the 2025 Sharp HealthCare lawsuit over ambient AI recording without patient consent.

AI in healthcare cannot replace the necessity for named, accountable humans to validate outputs, override errors, and ensure ethical, safe decision-making at every step.